Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

NCT03608618 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor shift in focus

Conditions

Peritoneal Mesothelioma
Fallopian Tube Adenocarcinoma
Adenocarcinoma of the Ovary
Primary Peritoneal Carcinoma

Interventions

BIOLOGICAL: MCY-M11
DRUG: Cyclophosphamide

Sponsor

MaxCyte, Inc.

Collaborators

[object Object]